NCT01881022

Brief Summary

Diagnosis and treatment of breast cancer often leads to lower levels of sexual desire, decreased sexual arousal, painful intercourse, and difficulties achieving orgasm, and thus adversely impacts sexual functioning and intimacy. Despite the overwhelming evidence that many couples experience sexual distress following breast cancer, very few interventions have been designed exclusively to address these concerns. The purpose of this study is to develop and evaluate an online psychosexual program geared to the unique needs of couples experiencing sexual distress after breast cancer. This study will utilize a web-based approach, allowing couples to participate in the program from the privacy and comfort of their homes, and providing a resource to couples who may not otherwise be able to readily access support. Accordingly, this project has the potential for widespread positive impact for couples affected by breast cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Jun 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 19, 2013

Completed
2 years until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

February 25, 2019

Status Verified

February 1, 2019

Enrollment Period

2.3 years

First QC Date

June 14, 2013

Last Update Submit

February 21, 2019

Conditions

Keywords

Breast CancerCouplesSexual DysfunctionPsychosexual InterventionSex TherapyOnline Supporte-health

Outcome Measures

Primary Outcomes (1)

  • Change in Sexual Function Questionnaire for Men and Women (SFQ-W, SFW-M) scores from pre (0 weeks) to post-treatment (6 weeks), and 3 month follow-up

    The SFQ assesses couples' sexual satisfaction and functioning. The SFQ will be used to assess change in couples' level of sexual functioning.

    pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up

Secondary Outcomes (7)

  • Revised Dyadic Adjustment Scale (RDAS)

    pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up

  • Maudsley Marital Questionnaire (marital sub-scale only)

    pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up

  • Profile of Mood States Short Form (POMS-SF)

    pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up

  • Centre for Epidemiological Studies Depression Scale

    pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up

  • Generalized Anxiety Disorder Assessment (GAD-7)

    pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up

  • +2 more secondary outcomes

Other Outcomes (1)

  • Program Expectancy Questionnaire

    Pre-treatment (0 weeks)

Study Arms (1)

Psychosexual Intervention

EXPERIMENTAL

The intervention will consist of 6 weekly sessions of couples psychosexual counseling delivered via videoconferencing.

Behavioral: Psychosexual Intervention

Interventions

Couples will complete six weekly psychosexual counselling sessions. Each session will focus on areas relevant to sex therapy and sexual dysfunction in couples facing breast cancer (e.g. education, communication, body imagery, sensate focusing, and problem solving). Sessions will be one hour in length (Note: Session 1 will be 1.5 hours), during which couples will meet with a facilitator via videoconferencing.

Psychosexual Intervention

Eligibility Criteria

AgeUp to 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient has received a diagnosis within the last 5 years of invasive breast carcinoma (non- metastatic), or ductal carcinoma in-situ
  • Patient has received a mastectomy or lumpectomy and undergone adjuvant therapy (i.e.
  • chemotherapy, radiation, tamoxifen)
  • Patient is at least 1 month post-treatment.
  • Couples are in a committed relationship of at least 3 months duration at the time of diagnosis
  • Participants must be fluent in English
  • Participants must be 80 years of age or younger
  • Participants will require convenient access to a computer with a reliable internet connection in a private setting and have access to videoconferencing software (available for download at no cost).

You may not qualify if:

  • One or both of the partners are currently struggling with any mental illness that would interfere with the ability to participate (e.g. actively suicidal; currently psychotic
  • Couples who plan to participate in couples or sex counselling during the study
  • Couples experiencing significant levels of relationship distress (e.g. presence of violence or abuse), in which case they will be referred for couple counseling

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunnbrook Odette Cancer Centre

Toronto, Ontario, M4N 3M5, Canada

Location

MeSH Terms

Conditions

Breast NeoplasmsSexual Dysfunction, Physiological

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesGenital DiseasesUrogenital Diseases

Study Officials

  • Karen Fergus, PhD

    Toronto Sunnybrook Regional Cancer Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 14, 2013

First Posted

June 19, 2013

Study Start

June 1, 2015

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

February 25, 2019

Record last verified: 2019-02

Locations